A PHASE III, OPEN-LABEL EXTENSION TRIAL OF ECU-MG-301 TO EVALUATE THE SAFETY AND EFFICACY OF ECULIZUMAB IN SUBJECTS WITH REFRACTORY GENERALIZED MYASTHENIA GRAVIS (gMG)
Principal Investigator(s)
Bhavaraju-Sanka,Ratna K.
Funded by
ALEXION PHARMACEUTICALS
Research Start Date
Status
Inactive